News | July 28, 2008

MRI Tracks Stem Cells in Heart

July 29, 2008 - For several years, doctors have known that certain stem cells migrate to the heart after a heart attack, but exactly how they get there and what purpose they serve remained uncertain.

Now for the first time, researchers have tracked the stem cells in mice using magnetic resonance imaging (MRI) from their bone marrow origin to the injured site. This opens up the possibility of finding some therapeutic treatment to direct these cells after a heart attack.

Mesenchymal stem cells, or MSCs, are found in the bone marrow and can differentiate into certain cell types. They have been detected around heart injuries following a myocardial infarction (heart attack), but whether they come to regenerate heart tissue or to promote healing is still under debate.

Using a series of MRI scans, Tom Hu and colleagues at the Medical College of Georgia in Augusta, GA, have tracked MS's in a sample of mice. The researchers first transplanted into the bone marrow a few hundred thousand MSCs that had been labeled with both iron-oxide (a molecule that essentially shades out the MRI signal) and a special protein that fluoresces when exposed to blue light. The team then operated on all of the mice, inducing a heart attack in one group. Over the following days, MRI scans showed a gradual darkening around the site of injury in the heart attack group, which was presumably due to the arrival of the labeled MSCs. The researchers validated this migration with fluorescent microscopy.

The goal now is to devise a way to attach an MRI-sensitive marker to MS's in humans who have suffered a heart attack. This would allow doctors to more closely study these cells, and perhaps devise treatments that can control their migration.

For more information: www.aapm.org

Source: American Association of Physicists in Medicine

Related Content

Russian Team Developing New Technology to Significantly Reduce MRI Research Costs
News | Magnetic Resonance Imaging (MRI)| January 16, 2018
January 16, 2018 — Researchers from the NUST MISIS Engineering Center for Industrial Technologies in Russia have deve
Videos | Magnetic Resonance Imaging (MRI)| December 13, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
GE Healthcare Launches Blanket-Like Air Technology MRI Coils
Technology | Magnetic Resonance Imaging (MRI)| December 13, 2017
GE Healthcare announced U.S. FDA 510(k) clearance of its new Air Technology, what it calls an industry-first suite of...
Toshiba Vantage Galan 3T XGO Edition MRI Features New Advanced Gradient
Technology | Magnetic Resonance Imaging (MRI)| December 11, 2017
Toshiba Medical, a Canon Group company, demonstrated the Vantage Galan 3T XGO Edition with the all-new Saturn X...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI)| December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
FDA Clears Siemens Magnetom Terra 7T MRI Device

The FDA has cleared the Siemens Magnetom Terra as the first 7T MRI system in the U.S. to gain regulatory approval.

Technology | Magnetic Resonance Imaging (MRI)| October 12, 2017
The U.S. Food and Drug Administration (FDA) cleared the first 7 Tesla (7T) magnetic resonance imaging (MRI) device,...
MR Solutions Showcases Multimodality MRI Solutions on Two Continents
News | Magnetic Resonance Imaging (MRI)| October 11, 2017
MR Solutions took their cryogen-free preclinical multimodality magnetic resonance imaging (MRI) solutions on tour in...
Toshiba Showcases MRI Workflow Enhancements at RSNA 2017
News | Magnetic Resonance Imaging (MRI)| September 21, 2017
September 21, 2017 — Toshiba Medical will highlight its latest...
GE Healthcxare Signa Pioneer MAGIC six contrasts in one scan software by SyntheticMR.

The MRI software enables several different contrasts to be obtained from one scan, shortening scan times.

Feature | Magnetic Resonance Imaging (MRI)| August 31, 2017
August 31, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for SyntheticMR’s SyMRI.
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Magnetic Resonance Imaging (MRI)| August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
Overlay Init